Internal Medicine, Rheumatology · Lafayette, LA
NPI
1316997984
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4212 W Congress St Ste 2300a
Lafayette, LA, 70506
Phone (337) 237-7801
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
236,459 services
Medicare patients, 2024
817
Average age 74
Drug cost, 2024
$3.4M
5,923 prescriptions
Company payments, 2025
$2,993
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer K Malin was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 150,000 times for 47 patients. In total Jennifer K Malin billed 236,459 services in 70 codes, and Medicare paid $1.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 150,000 | 47 | $3.59 | $539K |
| J3262 Injection, tocilizumab, 1 mg | Office | 43,725 | 16 | $4.71 | $206K |
| J0897 Injection, denosumab, 1 mg | Office | 11,400 | 117 | $20.45 | $233K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 9,850 | 15 | $33.77 | $333K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,108 | 61 | $0.10 | $317 |
| 96401 Chemotherapy Administration | Office | 1,668 | 135 | $29.31 | $49K |
| 36415 Venipuncture Blood Collection | Office | 944 | 516 | $8.63 | $8,149 |
| 99214 Office E&M - Established | Office | 906 | 626 | $84.75 | $77K |
| 82550 Clinical Chemistry | Office | 850 | 486 | $6.35 | $5,395 |
| 84550 Clinical Chemistry | Office | 845 | 484 | $4.41 | $3,729 |
| 82248 Clinical Chemistry | Office | 841 | 482 | $4.90 | $4,122 |
| 84100 Clinical Chemistry | Office | 840 | 482 | $4.63 | $3,891 |
| 80053 Clinical Chemistry | Office | 839 | 482 | $10.31 | $8,651 |
| 85025 Blood Count | Office | 810 | 473 | $7.57 | $6,133 |
| 85652 Clinical Chemistry | Office | 518 | 365 | $2.62 | $1,359 |
By year: 2022 $1.8M for 203,433 services; 2023 $1.8M for 230,468 services; 2024 $1.6M for 236,459 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 944 | 516 | $8.63 | $8,149 |
| 82550 Clinical Chemistry | 850 | 486 | $6.35 | $5,395 |
| 84550 Clinical Chemistry | 845 | 484 | $4.41 | $3,729 |
| 82248 Clinical Chemistry | 841 | 482 | $4.90 | $4,122 |
| 84100 Clinical Chemistry | 840 | 482 | $4.63 | $3,891 |
| 80053 Clinical Chemistry | 839 | 482 | $10.31 | $8,651 |
| 85025 Blood Count | 810 | 473 | $7.57 | $6,133 |
| 85652 Clinical Chemistry | 518 | 365 | $2.62 | $1,359 |
| 86140 Clinical Chemistry | 512 | 364 | $5.04 | $2,582 |
| 81003 Clinical Chemistry | 54 | 47 | $2.17 | $117 |
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer K Malin prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 958 prescriptions and refills. In total Jennifer K Malin wrote 5,923 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 958 | 1,395 | 217 | $17K |
| Hydroxychloroquine Sulfate Generic | 786 | 1,310 | 204 | $29K |
| Prednisone Generic | 708 | 912 | 192 | $3,396 |
| Sulfasalazine Generic | 421 | 722 | 107 | $10K |
| Alendronate Sodium Generic | 376 | 640 | 79 | $2,727 |
| Tramadol Hcl Generic | 327 | 327 | 48 | $1,337 |
| Allopurinol Generic | 265 | 468 | 63 | $1,702 |
| Celecoxib Generic | 188 | 263 | 54 | $4,770 |
| Meloxicam Generic | 173 | 245 | 44 | $661 |
| Leflunomide Generic | 146 | 248 | 43 | $7,657 |
| Diclofenac Sodium Generic | 139 | 165 | 37 | $1,934 |
| Humira(Cf) Pen Adalimumab | 139 | 154 | 17 | $1.2M |
| Duloxetine Hcl Generic | 138 | 200 | 21 | $1,441 |
| Mycophenolate Mofetil Generic | 120 | 174 | 25 | $15K |
| Febuxostat Generic | 109 | 135 | 24 | $8,587 |
Brand drugs: 1,141 claims; generic drugs: 4,771 claims; opioid claims: 339.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer K Malin $2,993 ($2,993 in general payments such as food, travel and fees) from 31 companies. The largest payer was Amgen Inc. with $588.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 32 | $588 |
| Janssen Biotech, Inc. JNJ | 6 | $296 |
| Abbvie Inc. ABBV | 13 | $285 |
| UCB, Inc. UCB.BR | 8 | $184 |
| Genzyme Corporation SNY | 7 | $176 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $169 |
| Radius Health, Inc. | 6 | $149 |
| Insulet Corporation PODD | 6 | $135 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $115 |
| Fresenius Kabi USA, LLC | 3 | $84.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.